DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment

Information source: Friends Research Institute, Inc.
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Opiate Dependence

Intervention: Patient-Centered Methadone Treatment (Other); Methadone Treatment as usual (Other)

Phase: Phase 3

Status: Active, not recruiting

Sponsored by: Friends Research Institute, Inc.

Official(s) and/or principal investigator(s):
Robert P Schwartz, M.D., Principal Investigator, Affiliation: Friends Research Institute, Inc.


The purpose of the study is to determine whether a change in the rules and staff roles in methadone treatment programs will result in greater lengths of stay in treatment and lower rates of heroin and cocaine use, crime and HIV-risk behavior as compared to methadone treatment as usual.

Clinical Details

Official title: Reengineering Methadone Treatment: A Randomized Clinical Trial

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Primary outcome: Urine test for opiates

Secondary outcome:

Urine cocaine drug test

HIV risk behavior

Criminal behavior

Quality of Life

Opiate dependence

Cocaine dependence

Detailed description: Early drop-out and premature discharge from methadone treatment is common in the United States and may be associated with drug use and its associated problems. The purpose of this study is to evaluate the effectiveness of a novel approach to the organization methadone treatment in which the patient rules and staff roles of the clinic will be modified for study participants as compared to patients receiving standard methadone treatment.


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- opiate dependence

- newly admitted to methadone treatment

Exclusion Criteria:

- pregnancy

Locations and Contacts

Institutes for Behavior Resources REACH, Baltimore, Maryland 21218, United States

University of Maryland Drug Treatment Center, Baltimore, Maryland 21223, United States

Additional Information

Starting date: September 2011
Last updated: March 5, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017